Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review
Objectives To inform an international task force about current evidence on Treat to Target
(T2T) strategies in PMR and GCA. Methods A systematic literature research (SLR) was …
(T2T) strategies in PMR and GCA. Methods A systematic literature research (SLR) was …
Evidence on treat to target strategies in polymyalgia rheumatica and giant cell arteritis: a systematic literature review
OBJECTIVES: To inform an international task force about current evidence on Treat to
Target (T2T) strategies in PMR and GCA. METHODS: A systematic literature research (SLR) …
Target (T2T) strategies in PMR and GCA. METHODS: A systematic literature research (SLR) …
[PDF][PDF] Do statins decrease vascular inflammation in patients at risk for large-vessel vasculitis? A retrospective observational study with FDG-PET/CT in polymyalgia …
F Iannuzzi, E Hysa, D Camellino… - Clinical and …, 2023 - researchgate.net
Objective [18F] Fluorodeoxyglucose (FDG) positron emission tomography/computed
tomography (PET/CT) can detect the presence of large-vessel vasculitis (LVV) in patients …
tomography (PET/CT) can detect the presence of large-vessel vasculitis (LVV) in patients …
[HTML][HTML] Fever Correlation with Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) Concentrations in Patients with Isolated Polymyalgia Rheumatica …
C Manzo, M Milchert, C Venditti, A Castagna, A Nune… - Life, 2022 - mdpi.com
Background: Polymyalgia rheumatica (PMR) is the most common systemic inflammatory
rheumatic disease affecting the elderly. Giant cell arteritis (GCA) is a granulomatous …
rheumatic disease affecting the elderly. Giant cell arteritis (GCA) is a granulomatous …
[HTML][HTML] Polymyalgia rheumatica and cancer: surveillance duration and other points to ponder
C Manzo, A Nune - Reumatologia, 2023 - ncbi.nlm.nih.gov
Polymyalgia rheumatica (PMR) is one of the most common inflammatory rheumatic disease
affecting the elderly [1]. Up to 20% of patients with PMR may develop giant cell arteritis …
affecting the elderly [1]. Up to 20% of patients with PMR may develop giant cell arteritis …
[HTML][HTML] Presence of subclinical giant cell arteritis in patients with morning stiffness of duration less than 45 minutes at the time of diagnosis of polymyalgia rheumatica
C Manzo, A Castagna, N Veronese, M Isetta - Reumatologia, 2023 - ncbi.nlm.nih.gov
Results We included a total of 143 patients (35 men and 108 women). Their median age
was of 71.5 years. Thirty-five had MS duration< 45 min at the time of PMR diagnosis …
was of 71.5 years. Thirty-five had MS duration< 45 min at the time of PMR diagnosis …